Search results
Here’s What Scientists Know About Paxlovid Rebound
Time via Yahoo News· 2 years agoCredit - dpa/picture alliance—Getty Images Dr. David Ho has spent his entire career studying HIV and other viruses, so he thought he knew what to expect...
Biology: Have we learned the lessons of COVID-19? Doubtful. And now we're facing monkeypox
The Columbus Dispatch via Yahoo News· 2 years agoKnowledge is power — but only if you use it. We know about viruses and how they reproduce. We know...
'It’s not gone. It’s changing. It’s killing': The COVID variants the WHO is watching closely
Euronews via Yahoo News· 5 months agoWhile the height of the pandemic may be over, the virus that causes COVID-19 continues to mutate...
COVID can stay in body 'for months', autopsies reveal
Yahoo News UK· 1 year agoCOVID-19 spreads through the whole body, and infects organs including the kidneys, heart, eye and...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2023 Earnings Call Transcript February 7, 2023...
"There's a lot we don't know": Why public health experts are worried about bird flu
Salon via Yahoo News· 2 weeks agoRooster chicken cage Texas Brandon Bell/Getty Images The Centers for Disease Control and Prevention...
Gilead's (GILD) Veklury Gets FDA Nod for Label Expansion
Zacks via Yahoo Finance· 9 months agoGilead's (GILD) antiviral treatment Veklury (remdesivir) has now been approved for the treatment of...
How China beat US pharma giant Gilead in the race to create a covid antiviral pill
Quartz· 2 years agoCovid is not going away. Covid vaccines are not foolproof. But endless waves of mass outbreaks,...
Q1 2023 Arbutus Biopharma Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 12 months agoParticipants David C. Hastings; CFO & CAO; Arbutus Biopharma Corporation Karen Sims Lisa M. Caperelli; VP of IR; Arbutus Biopharma Corporation Michael J. Sofia; Chief Scientific Officer; Arbutus ...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoArbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2022 Earnings Call Transcript March 2, 2023 Operator:...
